Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Degradation of Androgen Receptor through Small Molecules for Prostate Cancer.

Current cancer drug targets - 1 Jan 2018

Ge Raoling, Xu Xi, Xu Pengfei, Li Lei, Li Zhiyu, Bian Jinlei

Abstract excerpt

Prostate cancer is the most common carcinoma among aged males in western countries and more aggressive and lethal castration resistant prostate cancer often occurs after androgen deprivation therapy. The high expression of androgens and androgen receptor is closely related to prostate cancer. Efficient androgen receptor antagonists, such as enzalutamide and ARN-509, could be employed as potent anti-prostate...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Androgen Receptor Antagonists
Share to Androgens
Share to Docosahexaenoic Acids

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to HSP90 Heat-Shock Proteins

Share to Prostatic Neoplasms, Castration-Resistant

Share to Proteolysis

Share to Ubiquitination

Share to Ubiquitins

Source

Identifiers

PMID: 29110617
DOI: 10.2174/1568009617666171107103936

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Degradation of Androgen Receptor through Small Molecules for Prostate Cancer.PMID 29110617Read ↗

Selective androgen receptor degrader (SARD) to overcome antiandrogen resistance in castration-resistant prostate cancerSemantic proximity Read ↗

Androgen Receptor Signaling Pathway in Prostate Cancer: From Genetics to Clinical ApplicationsSemantic proximity Read ↗

Manipulation of androgens and alterations in the androgen receptor axis in prostate cancer.Semantic proximity Read ↗

Dissecting the roles of the androgen receptor in prostate cancer from molecular perspectives.Semantic proximity Read ↗

ASC-J9(®) suppresses castration resistant prostate cancer progression via degrading the enzalutamide-induced androgen receptor mutant AR-F876L.Semantic proximity Read ↗

Loss and revival of androgen receptor signaling in advanced prostate cancerSemantic proximity Read ↗

Discovery of a Small-Molecule Inhibitor Targeting the Androgen Receptor N-Terminal Domain for Castration-Resistant Prostate CancerSemantic proximity Read ↗

Targeting the androgen receptor pathway in castration-resistant prostate cancer: progresses and prospectsSemantic proximity Read ↗

Androgen deprivation therapy for prostate cancer: current status and future prospects.Semantic proximity Read ↗

Novel hormone therapies for advanced prostate cancer: Understanding and countering drug resistanceSemantic proximity Read ↗

Androgen receptor plasticity and its implications for prostate cancer therapy.Semantic proximity Read ↗

Androgen Receptor Signaling in Prostate Cancer and Therapeutic StrategiesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.